Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EffRx Pharmaceuticals signs exclusive license agreement with Diurnal for registration and commercialisation of Alkindi

pharmaceutical-business-reviewOctober 26, 2020

Tag: EffRx Pharmaceuticals , Diurnal , Alkindi

PharmaSources Customer Service